non glp 1 weight loss drugs GLP-1 drugs: Lower dose or oral pill may help sustain Atrafen GLP Ultra GLP-1 Appetite
Description
May 30, 2025
November 27, 2024: Researchers Warn of Kidney Injury Risk When Taking Ozempic A recent research study suggested that some patients taking GLP-1 drugs like Ozempic may experience acute kidney injuries, such as acute interstitial nephritis (AIN)
The analysis was based on 15,264 women with and 15,264 matched women without GLP-1 exposure
California officials projected that continuing to cover the drugs for weight loss could have cost nearly $800 million annually within a few years
This seems counterintuitiveand there are some valid concerns about giving a drug that makes people less hungry to those already consuming too little
Patients often seek out compounded versions of the medications because the brand-name versions are expensive, she said
